Finance

Lists
Why is ALIVUS up 2.61%?
Dive Deeper
ALIVUS:NSE
Alivus Life Sciences Ltd
₹1,520.00
+2.61%
(+38.70) 1D
Nov 4, 3:30:01 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ALIVUS...
Open
₹1,475.00
High
₹1,529.00
Low
₹1,450.10
Mkt. cap
186.91B
Avg. vol.
174.97K
Volume
487.35K
Dividend
0.33%
Quarterly dividend
₹1.25
Ex-dividend date
Sep 1, 2026
P/E ratio
27.93
52-wk high
₹1,529.00
52-wk low
₹819.00
EPS
₹54.43
No. of employees
2K
Open
₹1,475.00
High
₹1,529.00
Low
₹1,450.10
Mkt. cap
186.91B
Avg. vol.
174.97K
Volume
487.35K
Dividend
0.33%
Quarterly dividend
₹1.25
Ex-dividend date
Sep 1, 2026
P/E ratio
27.93
52-wk high
₹1,529.00
52-wk low
₹819.00
EPS
₹54.43
No. of employees
2K
News stories
From web sources and news partners
About Alivus Life Sciences Ltd
CEOYasir Rawjee
Employees2.27K
Founded2001
Headquarters-
SectorPharmaceutical industry
Industry-
Websitealivus.com
Last report
Oct 29, 2026
Fiscal period
Q2 2027
₹15.98 / ₹12.50
+27.84%beat
Revenue / Est. (INR)
6.82B / 6.42B
+6.21%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
6.73B
6.89B
6.40B
6.82B
Cost of goods sold
2.76B
3.45B
2.55B
2.43B
Cost of revenue
2.76B
3.45B
2.55B
2.43B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
663.70M
965.39M
682.45M
696.12M
Operating expense
1.85B
1.49B
1.94B
1.96B
Total operating expenses
4.61B
4.94B
4.49B
4.39B
Operating income
2.12B
1.95B
1.91B
2.43B
Other non operating income
139.28M
-368.69M
224.01M
199.17M
EBT including unusual items
1.98B
2.16B
2.12B
2.62B
EBT excluding unusual items
2.24B
1.78B
2.12B
2.62B
Income tax expense
481.31M
531.38M
521.47M
652.29M
Effective tax rate
24.26%
24.62%
24.57%
24.90%
Other operating expenses
988.28M
325.80M
1.05B
1.04B
Net income
1.50B
1.63B
1.60B
1.97B
Net profit margin
22.33%
23.60%
25.00%
28.85%
Earnings per share
13.80
13.22
13.01
15.98
Interest and investment income
-
9.66M
-
-
Interest expense
-14.94M
-13.09M
-13.07M
-13.06M
Net interest expenses
-14.94M
-3.43M
-13.07M
-13.06M
Depreciation and amortization charges
196.58M
202.00M
205.85M
218.24M
EBITDA
2.25B
2.11B
2.10B
2.65B
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps